Esketamine-supported opioid-free anesthesia in the bariatric surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057066

Enrollment

Unknown

Registered

2022-02-27

Start date

2022-03-01

Completion date

Unknown

Last updated

2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Esketamine group:Esketamine

Opioid group:Opioid drugs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing electric bariatric surgery. All the included experimental subjects signed a written informed consent form; 2. Age 18-50 years old; 3. American Society of Anesthesiologists ASA classification I to III; 4. BMI> 40 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy to related anesthetics; 2. Patients refused to cooperate; 3. Severe cardiopulmonary disease or craniocerebral injury or mental illness; 4. Uncontroled hypertensive patients.

Design outcomes

Primary

Measure	Time frame
Postoperative respiratory function;Postoperative pain;	—

Secondary

Measure	Time frame
Adverse reaction;	—

Countries

China

Contacts

Public ContactHeliang Sun

The First Affiliated Hospital of Nanjing Medical University

njmu528@163.com+86 18205188566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026